ACG 2025
24 - 29 October 2025
The Use of Non-Invasive Tests to Characterise the Total Baseline Population in the Phase 3 Essence Trial
Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.